Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
drug prices
5
×
indiana blog main
indiana top stories
life sciences
medicare
national
national blog main
national top stories
new york blog main
new york top stories
novartis
5
×
raleigh-durham blog main
5
×
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
pfizer
abbvie
alzheimer's disease
biogen
bristol-myers squibb
cancer immunotherapy
deals
eli lilly
gilead sciences
immunotherapy
What
drug
bio
price
roundup
companies
pharmaceutical
prices
today
acquisitions
airport
albert
alzheimer’s
annual
apocalypse
approval
away
beds
biggest
biogen’s
biopharmaceutical
bourla
bringing
celgene
ceo
ceos
company
convo
crispr
days
dc
different
earlier
executives
fail
failures
fallout
future
gathered
gene
gone
Language
unknown
Current search:
novartis
×
" drug prices "
×
" raleigh-durham blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More